Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty

Summary

Primary aim of the study is to determine whether a rho kinase inhibitor, Netarsudil, can speed corneal clearance after DWEK. Secondary aim of the study is to investigate whether patient factors, such as baseline age, pachymetry, or endothelial cell count influence response to Netarsudil.

Timeline

Start

2018-10-02

Primary completion

2020-12-20

Completion

2020-12-20

Drugs

Indications